Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Microsoft
MSFT
|
+$870M |
| 3 |
Amazon
AMZN
|
+$600M |
| 4 |
Meta Platforms (Facebook)
META
|
+$343M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$52.4M |
| 2 |
ZAYO
Zayo Group Holdings, Inc.
ZAYO
|
+$32.8M |
| 3 |
LPT
Liberty Property Trust
LPT
|
+$29.6M |
| 4 |
MDCO
Medicines Co
MDCO
|
+$12.9M |
| 5 |
INXN
Interxion Holding N.V.
INXN
|
+$12.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.52% |
| 2 | Healthcare | 15.94% |
| 3 | Consumer Discretionary | 11.41% |
| 4 | Communication Services | 10.51% |
| 5 | Consumer Staples | 8.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TPIC
1951
DELISTED
TPI Composites
TPIC
| $807K | ﹤0.01% |
54,600
+800
| +1% | +$15.7K |
|
|
VRN
1952
DELISTED
Veren
VRN
| $807K | ﹤0.01% |
1,061,100
+10,200
| +1% | +$28.2K |
|
1953
Viper Energy
VNOM
$15.2B
| $806K | ﹤0.01% |
121,500
+1,600
| +1% | +$29.1K |
|
1954
Atara Biotherapeutics
ATRA
$83.1M
| $804K | ﹤0.01% |
3,780
+80
| +2% | +$25.4K |
|
|
DCOM
1955
DELISTED
Dime Community Bancshares
DCOM
| $802K | ﹤0.01% |
58,500
| – | – |
|
1956
Anika Therapeutics
ANIK
$295M
| $801K | ﹤0.01% |
27,700
+1,300
| +5% | +$52.6K |
|
1957
Intellia Therapeutics
NTLA
$1.69B
| $801K | ﹤0.01% |
65,500
| – | – |
|
1958
The RMR Group
RMR
$337M
| $801K | ﹤0.01% |
29,692
+600
| +2% | +$23.2K |
|
|
ARCH
1959
DELISTED
Arch Resources, Inc.
ARCH
| $801K | ﹤0.01% |
27,700
-1,800
| -6% | -$92.2K |
|
|
NWLI
1960
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $800K | ﹤0.01% |
4,649
+100
| +2% | +$24.5K |
|
|
XRN
1961
Chiron Real Estate Inc
XRN
$480M
| $799K | ﹤0.01% |
15,800
+220
| +1% | +$14.8K |
|
1962
Johnson Outdoors
JOUT
$499M
| $796K | ﹤0.01% |
12,700
| – | – |
|
|
HSKA
1963
DELISTED
Heska Corp
HSKA
| $796K | ﹤0.01% |
14,400
+300
| +2% | +$27.2K |
|
1964
Evolent Health
EVH
$471M
| $795K | ﹤0.01% |
146,500
+2,000
| +1% | +$17.9K |
|
1965
Kelly Services Class A
KELYA
$536M
| $791K | ﹤0.01% |
62,300
+900
| +1% | +$15.7K |
|
1966
Arbor Realty Trust
ABR
$974M
| $790K | ﹤0.01% |
161,151
+7,600
| +5% | +$92.9K |
|
1967
QCR Holdings
QCRH
$1.73B
| $789K | ﹤0.01% |
29,139
+400
| +1% | +$15.2K |
|
|
SA
1968
Seabridge Gold
SA
$3.5B
| $789K | ﹤0.01% |
86,100
+1,500
| +2% | +$17.7K |
|
|
DCH
1969
Dauch Corp
DCH
$1.61B
| $787K | ﹤0.01% |
218,100
+2,800
| +1% | +$20.8K |
|
1970
Angi Inc
ANGI
$176M
| $786K | ﹤0.01% |
14,970
-670
| -4% | -$49.8K |
|
1971
Buckle
BKE
$2.33B
| $786K | ﹤0.01% |
57,300
+800
| +1% | +$18K |
|
1972
Dave & Buster's
PLAY
$361M
| $782K | ﹤0.01% |
59,773
-9,800
| -14% | -$336K |
|
1973
Horizon Bancorp
HBNC
$1.05B
| $774K | ﹤0.01% |
78,450
+900
| +1% | +$13.8K |
|
|
UMH
1974
UMH Properties
UMH
$1.39B
| $774K | ﹤0.01% |
71,300
+1,700
| +2% | +$24.7K |
|
1975
Pacific Biosciences
PACB
$345M
| $772K | ﹤0.01% |
252,246
+3,400
| +1% | +$13.9K |
|
Similar funds
Swiss National Bank's Q1 2020 Portfolio in Review
As of Q1 2020, Swiss National Bank held 2,510 positions worth $94.2B, down 3.4% from $97.5B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Swiss National Bank deployed $18.4B of net new capital in Q1 2020, opening 4 new positions and adding to 1,998 existing holdings. Its largest new stake was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was C.H. Robinson, an estimated $5.64M trimmed.
- Swiss National Bank's largest Q1 2020 buy was Luckin Coffee Inc. American Depositary Shares: 165,417 shares worth $4.5M.
- Swiss National Bank added most to Apple in Q1 2020, an estimated $883M increase.
- Swiss National Bank's biggest Q1 2020 reduction was C.H. Robinson, cutting an estimated $5.64M.
- Swiss National Bank fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $52.4M.
- Swiss National Bank's ten largest holdings make up 22% of its $94.2B portfolio in Q1 2020.
- Swiss National Bank opened 4 new positions and closed 30 in Q1 2020.
- Swiss National Bank's portfolio value fell 3.4% quarter-over-quarter to $94.2B.
Based on Swiss National Bank's 13F filing for Q1 2020, filed 8 May 2020.